"I Want to Know Everything ... ": The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2023
Historique:
medline: 19 9 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: ppublish

Résumé

Although African Americans experience the highest risk of Alzheimer's disease (AD), they are dramatically underrepresented in preclinical biomarker research. This is especially true for studies involving lumbar puncture as it may involve more perceived risk even for those participants who are otherwise supportive of research. To understand the unique concerns of African American participants regarding biomarker studies involving lumbar puncture who demonstrate support for AD research. Study participants were African American adults contacted through an AD research registry. We employed a novel method used to create hypothetical research studies varying on a set number of factors. The method is designed to collect potential patterns in decision making regarding research participation but differs from experimental vignette design in that the survey is administered with an accompanying qualitive interview to determine the meaning participants ascribe to factors independently and in conjunction with one another. Sixty-one participants each reviewed three randomly selected research scenarios and created their "ideal" study involving lumbar puncture. Scenario variables included: disclosure of research results, racial and ethnic identity of the researcher, recruitment method, and amount of incentive. Findings indicate that transparency in the return of AD research results to be the strongest driver of participation, followed by race of the researcher and amount of incentive. Recruitment method had limited impact on hypothetical decision making.

Sections du résumé

BACKGROUND
Although African Americans experience the highest risk of Alzheimer's disease (AD), they are dramatically underrepresented in preclinical biomarker research. This is especially true for studies involving lumbar puncture as it may involve more perceived risk even for those participants who are otherwise supportive of research.
OBJECTIVE
To understand the unique concerns of African American participants regarding biomarker studies involving lumbar puncture who demonstrate support for AD research.
METHODS
Study participants were African American adults contacted through an AD research registry. We employed a novel method used to create hypothetical research studies varying on a set number of factors. The method is designed to collect potential patterns in decision making regarding research participation but differs from experimental vignette design in that the survey is administered with an accompanying qualitive interview to determine the meaning participants ascribe to factors independently and in conjunction with one another.
RESULTS
Sixty-one participants each reviewed three randomly selected research scenarios and created their "ideal" study involving lumbar puncture. Scenario variables included: disclosure of research results, racial and ethnic identity of the researcher, recruitment method, and amount of incentive.
CONCLUSION
Findings indicate that transparency in the return of AD research results to be the strongest driver of participation, followed by race of the researcher and amount of incentive. Recruitment method had limited impact on hypothetical decision making.

Identifiants

pubmed: 37574732
pii: JAD230275
doi: 10.3233/JAD-230275
pmc: PMC10637283
mid: NIHMS1940578
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-675

Subventions

Organisme : NIA NIH HHS
ID : P30 AG062715
Pays : United States
Organisme : NHGRI NIH HHS
ID : R21 HG011503
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002373
Pays : United States

Références

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):485-90
pubmed: 23728297
Public Health Genomics. 2019;22(5-6):215-226
pubmed: 31955173
JAMA Netw Open. 2021 Jul 1;4(7):e2114606
pubmed: 34228130
J Am Geriatr Soc. 2010 Sep;58(9):1758-63
pubmed: 20863335
J Clin Transl Sci. 2021 Jul 14;5(1):e159
pubmed: 34527298
Am J Public Health. 2013 Dec;103(12):2119-21
pubmed: 24134371
J Health Psychol. 2019 Sep;24(11):1548-1561
pubmed: 29172809
Health Aff (Millwood). 2022 Oct;41(10):1423-1432
pubmed: 36190895
Alzheimers Dement. 2016 May;12(5):614-22
pubmed: 26988427
J Cancer Educ. 2014 Sep;29(3):580-7
pubmed: 24243440
Med Care. 2018 Oct;56 Suppl 10 Suppl 1:S6-S8
pubmed: 30015725
Alzheimers Dement (N Y). 2019 Nov 19;5:751-770
pubmed: 31921966
Am J Community Psychol. 2020 Dec;66(3-4):302-313
pubmed: 32652706
Trends Mol Med. 2021 Feb;27(2):97-100
pubmed: 33277159
BMJ Open. 2019 Mar 03;9(3):e026468
pubmed: 30833325
BMC Med Ethics. 2015 Sep 09;16:60
pubmed: 26354520
Am J Public Health. 2014 Sep;104(9):1615-23
pubmed: 25033119
JAMA Neurol. 2019 Mar 1;76(3):264-273
pubmed: 30615028
Soc Sci Med. 2001 Mar;52(5):797-808
pubmed: 11218181
J Aging Stud. 2018 Mar;44:45-51
pubmed: 29502789
J Alzheimers Dis. 2020;77(4):1559-1567
pubmed: 32925041
Am J Prev Med. 2017 Jan;52(1S1):S86-S94
pubmed: 27989297
Geriatr Nurs. 2018 Nov;39(6):646-652
pubmed: 29804688
Curr Opin Psychiatry. 2020 Mar;33(2):136-140
pubmed: 31770136
Ann Epidemiol. 2008 Apr;18(4):335-41
pubmed: 18083547
BMC Med Res Methodol. 2011 Sep 09;11:128
pubmed: 21902844
J Alzheimers Dis. 2022;87(3):1167-1179
pubmed: 35466937
J Law Med Ethics. 2018 Sep;46(3):699-703
pubmed: 30336111
J Health Care Poor Underserved. 2016;27(2):722-40
pubmed: 27180705
Qual Health Res. 2016 May;26(6):830-41
pubmed: 25769299
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24 Suppl:S24-9
pubmed: 20711059
J Health Care Poor Underserved. 2010 Aug;21(3):879-97
pubmed: 20693733
Neurobiol Aging. 2016 Mar;39:147-53
pubmed: 26923411
Public Health Nurs. 2021 Nov;38(6):1102-1115
pubmed: 34240459
Am J Geriatr Psychiatry. 2018 Mar;26(3):316-331
pubmed: 29426607
JAMA Neurol. 2019 Mar 1;76(3):251-253
pubmed: 30615027
Alzheimers Dement (Amst). 2021 Feb 20;13(1):e12150
pubmed: 33665341
Genet Med. 2016 Jul;18(7):663-71
pubmed: 26583683
Alzheimers Dement (N Y). 2016 Oct 15;3(1):57-64
pubmed: 29067319
J Clin Transl Sci. 2021 Nov 11;6(1):e4
pubmed: 35154814
Int J Equity Health. 2022 Sep 10;21(1):130
pubmed: 36088334
Neurology. 2015 Apr 7;84(14):1488-94
pubmed: 25762713
Front Aging Neurosci. 2016 Dec 02;8:296
pubmed: 27994549

Auteurs

Susan Racine Passmore (SR)

Collaborative Center for Health Equity, Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
School of Nursing, University of Wisconsin, Madison, WI, USA.

Colin Longhurst (C)

Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.

Abigail Gerbitz (A)

Collaborative Center for Health Equity, Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.

Gina Green-Harris (G)

Center for Community Engagement and Health Partnerships, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.

Nia Norris (N)

Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.

Dorothy Farrar Edwards (DF)

Collaborative Center for Health Equity, Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Department of Kinesiology, School of Education, University of Wisconsin, Madison, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH